Exchange: NYSEMkt·Updated 03:17 PM EDT
PTHS logo

PTHS Pelthos Therapeutics Inc.

$25.74
$0.92
(3.71%)
Today
Reported EarningsAug 13
Mkt Cap$95.02M
Vol73,596.00

About PTHS

Pelthos Therapeutics, Inc. engages in the provision of therapeutic products. It produces products under its proprietary nitic oxide-based technology platform Nitricil. Its main product is a topical gel for the treatment of molluscum contagiosum. The company was founded on March 19, 2021 and is headquartered in Durham, NC.
47

Neutral Sentiment

How do you feel about PTHS?

Advertisement|Remove ads.